Compare $AKTX vs $CLRB | Chartloom

Compare

$AKTX vs $CLRB

Akari Therapeutics PLC · Cellectar Biosciences Inc

AKTX

Akari Therapeutics PLC

CLRB

Cellectar Biosciences Inc

Compare $AKTX vs $CLRB

Comparing Akari Therapeutics PLC and Cellectar Biosciences Inc

AKTXAkari Therapeutics PLC

CLRBCellectar Biosciences Inc

AKTXAkari Therapeutics PLC

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-24.4%

52W performance

-78.5%

FCF yield

-63.0%

CLRBCellectar Biosciences Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-58.2%

52W performance

-69.7%

FCF yield

-168.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTX

CLRB

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

CLRB

Cellectar Biosciences Inc

Market Cap

AKTX$17M

CLRB$12M

Enterprise Value

AKTX$10M

CLRB$-22M

Price

AKTX$8.77

CLRB$1.45

P/E Ratio

AKTXN/A

CLRBN/A

P/S Ratio

AKTX0.00x

CLRB186.94x

EV/Sales

AKTX0.00x

CLRB-190.77x

EV/EBITDA

AKTX0.00x

CLRB0.00x

P/B Ratio

AKTX0.83x

CLRB0.56x

P/FCF Ratio

AKTXN/A

CLRBN/A

EV/FCF

AKTX-0.94x

CLRB1.15x

PEG Ratio

AKTXN/A

CLRBN/A

Forward P/E (NTM)

AKTXN/A

CLRBN/A

Forward P/S (NTM)

AKTXN/A

CLRBN/A

Revenue (TTM)

AKTX$0

CLRB$0

Revenue Growth (YoY)

AKTXN/A

CLRBN/A

Forward Rev Growth

AKTX137.9%

CLRB585.7%

Gross Margin (TTM)

AKTX0.0%

CLRB0.0%

Operating Margin (TTM)

AKTX0.0%

CLRB0.0%

EBITDA Margin (TTM)

AKTX0.0%

CLRB0.0%

Net Margin (TTM)

AKTX0.0%

CLRB0.0%

FCF Margin (TTM)

AKTXN/A

CLRBN/A

Net Income (TTM)

AKTX$-31M

CLRB$-22M

FCF (TTM)

AKTX$-11M

CLRB$-19M

EPS (TTM)

AKTX-$0.40

CLRB-$1.83

ROE (TTM)

AKTX-14745.0%

CLRB-16571.0%

ROA (TTM)

AKTX-7470.0%

CLRB-11542.0%

ROIC (TTM)

AKTX-14027.0%

CLRB-16571.0%

Cash

AKTX$8M

CLRB$34M

Debt

AKTX$693K

CLRB$0

Net Cash/Debt

AKTX$7M

CLRB$34M

Current Ratio (TTM)

AKTX0.60x

CLRB6.66x

Quick Ratio (TTM)

AKTX0.56x

CLRB6.49x

Debt/Equity (TTM)

AKTX0.04x

CLRB0.00x

Debt/Assets (TTM)

AKTX0.0%

CLRB0.0%

Interest Coverage (TTM)

AKTXN/A

CLRBN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

CLRB0.00x

Beta

AKTX1.48

CLRB0.58

52W Performance

AKTX-78.5%

CLRB-69.7%

YTD Performance

AKTX-24.4%

CLRB-58.2%

% from 52W High

AKTX-79.5%

CLRB-71.4%

% from 52W Low

AKTX190.4%

CLRB8.2%

Asset Turnover (TTM)

AKTX0.00x

CLRB0.01x

FCF Yield (TTM)

AKTX-63.0%

CLRB-168.2%

Earnings Yield (TTM)

AKTX-181.3%

CLRB-192.7%

Dividend Yield (TTM)

AKTXN/A

CLRBN/A

Rule of 40

AKTX0.0

CLRB0.0

EV/GP/RG

AKTXN/A

CLRBN/A

Ticker research

View AKTX research View CLRB research

Metric	AKTX Akari Therapeutics PLC	CLRB Cellectar Biosciences Inc
Market & Valuation
Market Cap	$17M	$12M
Enterprise Value	$10M	$-22M
Price	$8.77	$1.45
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	186.94x
EV/Sales	0.00x	-190.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	1.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	137.9%	585.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-22M
FCF (TTM)	$-11M	$-19M
EPS (TTM)	-$0.40	-$1.83
ROE (TTM)	-14745.0%	-16571.0%
ROA (TTM)	-7470.0%	-11542.0%
ROIC (TTM)	-14027.0%	-16571.0%
Financial Health
Cash	$8M	$34M
Debt	$693K	$0
Net Cash/Debt	$7M	$34M
Current Ratio (TTM)	0.60x	6.66x
Quick Ratio (TTM)	0.56x	6.49x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.58
52W Performance	-78.5%	-69.7%
YTD Performance	-24.4%	-58.2%
% from 52W High	-79.5%	-71.4%
% from 52W Low	190.4%	8.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-63.0%	-168.2%
Earnings Yield (TTM)	-181.3%	-192.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View CLRB research

Valuation

P/S Ratio

AKTX

0.00x

CLRB

186.94x

EV/FCF

AKTX

-0.94x

CLRB

1.15x

Growth & revenue

Forward Revenue Growth

CLRB

585.7%

AKTX

137.9%

Profitability & performance

Gross Margin

AKTX

0.0%

CLRB

0.0%

ROE

AKTX

-14745.0%

CLRB

-16571.0%

FCF Yield %

AKTX

-63.0%

CLRB

-168.2%

52-Week Performance

CLRB

-69.7%

AKTX

-78.5%

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

CLRB

Cellectar Biosciences Inc

Market Cap

AKTX$17M

CLRB$12M

Enterprise Value

AKTX$10M

CLRB$-22M

Price

AKTX$8.77

CLRB$1.45

P/E Ratio

AKTXN/A

CLRBN/A

P/S Ratio

AKTX0.00x

CLRB186.94x

EV/Sales

AKTX0.00x

CLRB-190.77x

EV/EBITDA

AKTX0.00x

CLRB0.00x

P/B Ratio

AKTX0.83x

CLRB0.56x

P/FCF Ratio

AKTXN/A

CLRBN/A

EV/FCF

AKTX-0.94x

CLRB1.15x

PEG Ratio

AKTXN/A

CLRBN/A

Forward P/E (NTM)

AKTXN/A

CLRBN/A

Forward P/S (NTM)

AKTXN/A

CLRBN/A

Revenue (TTM)

AKTX$0

CLRB$0

Revenue Growth (YoY)

AKTXN/A

CLRBN/A

Forward Rev Growth

AKTX137.9%

CLRB585.7%

Gross Margin (TTM)

AKTX0.0%

CLRB0.0%

Operating Margin (TTM)

AKTX0.0%

CLRB0.0%

EBITDA Margin (TTM)

AKTX0.0%

CLRB0.0%

Net Margin (TTM)

AKTX0.0%

CLRB0.0%

FCF Margin (TTM)

AKTXN/A

CLRBN/A

Net Income (TTM)

AKTX$-31M

CLRB$-22M

FCF (TTM)

AKTX$-11M

CLRB$-19M

EPS (TTM)

AKTX-$0.40

CLRB-$1.83

ROE (TTM)

AKTX-14745.0%

CLRB-16571.0%

ROA (TTM)

AKTX-7470.0%

CLRB-11542.0%

ROIC (TTM)

AKTX-14027.0%

CLRB-16571.0%

Cash

AKTX$8M

CLRB$34M

Debt

AKTX$693K

CLRB$0

Net Cash/Debt

AKTX$7M

CLRB$34M

Current Ratio (TTM)

AKTX0.60x

CLRB6.66x

Quick Ratio (TTM)

AKTX0.56x

CLRB6.49x

Debt/Equity (TTM)

AKTX0.04x

CLRB0.00x

Debt/Assets (TTM)

AKTX0.0%

CLRB0.0%

Interest Coverage (TTM)

AKTXN/A

CLRBN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

CLRB0.00x

Beta

AKTX1.48

CLRB0.58

52W Performance

AKTX-78.5%

CLRB-69.7%

YTD Performance

AKTX-24.4%

CLRB-58.2%

% from 52W High

AKTX-79.5%

CLRB-71.4%

% from 52W Low

AKTX190.4%

CLRB8.2%

Asset Turnover (TTM)

AKTX0.00x

CLRB0.01x

FCF Yield (TTM)

AKTX-63.0%

CLRB-168.2%

Earnings Yield (TTM)

AKTX-181.3%

CLRB-192.7%

Dividend Yield (TTM)

AKTXN/A

CLRBN/A

Rule of 40

AKTX0.0

CLRB0.0

EV/GP/RG

AKTXN/A

CLRBN/A

Ticker research

View AKTX research View CLRB research

Metric	AKTX Akari Therapeutics PLC	CLRB Cellectar Biosciences Inc
Market & Valuation
Market Cap	$17M	$12M
Enterprise Value	$10M	$-22M
Price	$8.77	$1.45
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	186.94x
EV/Sales	0.00x	-190.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	1.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	137.9%	585.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-22M
FCF (TTM)	$-11M	$-19M
EPS (TTM)	-$0.40	-$1.83
ROE (TTM)	-14745.0%	-16571.0%
ROA (TTM)	-7470.0%	-11542.0%
ROIC (TTM)	-14027.0%	-16571.0%
Financial Health
Cash	$8M	$34M
Debt	$693K	$0
Net Cash/Debt	$7M	$34M
Current Ratio (TTM)	0.60x	6.66x
Quick Ratio (TTM)	0.56x	6.49x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.58
52W Performance	-78.5%	-69.7%
YTD Performance	-24.4%	-58.2%
% from 52W High	-79.5%	-71.4%
% from 52W Low	190.4%	8.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-63.0%	-168.2%
Earnings Yield (TTM)	-181.3%	-192.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View CLRB research